Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EXENATIDE Cause Injection site haemorrhage? 5,527 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5,527 reports of Injection site haemorrhage have been filed in association with EXENATIDE (Exenatide). This represents 17.7% of all adverse event reports for EXENATIDE.

5,527
Reports of Injection site haemorrhage with EXENATIDE
17.7%
of all EXENATIDE reports
1
Deaths
126
Hospitalizations

How Dangerous Is Injection site haemorrhage From EXENATIDE?

Of the 5,527 reports, 1 (0.0%) resulted in death, 126 (2.3%) required hospitalization, and 8 (0.1%) were considered life-threatening.

Is Injection site haemorrhage Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EXENATIDE. However, 5,527 reports have been filed with the FAERS database.

What Other Side Effects Does EXENATIDE Cause?

Device leakage (5,115) Injection site pain (4,577) Injection site mass (3,506) Blood glucose increased (3,363) Incorrect dose administered by device (3,332) Device malfunction (3,273) Wrong technique in device usage process (3,255) Device issue (2,862) Weight decreased (2,702) Injection site extravasation (2,320)

What Other Drugs Cause Injection site haemorrhage?

ADALIMUMAB (11,715) ETANERCEPT (4,674) TIRZEPATIDE (4,389) EVOLOCUMAB (3,720) DULAGLUTIDE (3,028) TERIPARATIDE (2,330) GALCANEZUMAB-GNLM (1,415) DUPILUMAB (1,401) HUMIRA (1,304) INSULIN GLARGINE (1,221)

Which EXENATIDE Alternatives Have Lower Injection site haemorrhage Risk?

EXENATIDE vs EXFORGE EXENATIDE vs EXJADE EXENATIDE vs EXTAVIA EXENATIDE vs EXTRANEAL EXENATIDE vs EYLEA

Related Pages

EXENATIDE Full Profile All Injection site haemorrhage Reports All Drugs Causing Injection site haemorrhage EXENATIDE Demographics